Discover 1,104 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,104
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: 54 recruiting locations
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
for
HER2-positive Metastatic Breast Cancer
Location: 29 recruiting locations
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT06551116
Recruiting
Active & Responsive
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: 99 recruiting locations
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Active & Responsive
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
for
Crohn Disease, Colitis, Ulcerative
Location: 11 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0+
Code: NCT06651281
Phase3, Recruiting
Active & Responsive
A Study of ASP1002 in Adults for Treatment of Solid Tumors
for
Advanced Solid Tumors
Location: 12 recruiting locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05719558
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
for
OCD, Major Depressive Disorder (MDD),
Location: 2 recruiting locations
Sponsor: Yale University
Sex: All
Age: 18 - 65
Code: NCT06624137
Recruiting
Active & Responsive
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis, Ulcerative Colitis Chronic
Location: 23 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06598943
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: 77 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
Active & Responsive
Identifying and Characterizing Preclinical MS
for
Multiple Sclerosis
Location: 1 recruiting location
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05787795
Recruiting
Active & Responsive
Immunometabolic Mechanisms of Blood Flow Restriction (BFR) Training After Anterior Cruciate Ligament Reconstruction